Abbott Introduces the Alinity hq Hematology Analyzer, the Newest Addition to the Alinity Family of Harmonized Systems
- The Alinity hq next generation system is designed to streamline workflow and transform operational performance to help laboratories and hospital systems achieve measurably better healthcare performance

ABBOTT PARK, Ill., June 14, 2017 — Abbott announced today that the Alinity hq analyzer for hematology is now CE Marked and available in Europe and other countries that recognize CE Mark. The analyzer is the first in the Alinity hematology series of instruments to be commercially released, and is part of the planned integrated hematology system designed to address the productivity needs of the high-volume laboratory.

Hematology is a medical specialty dedicated to studying the physiology of blood, and the cause, diagnosis, treatment, and prevention of diseases related to blood. In diagnostics testing, hematology tests look at blood composition, which includes the identification and quantification of different types of blood cells. The Alinity hq analyzer automates the performance of these tests and reports on 29 different parameters within a matter of minutes.

"The Alinity hq launch is a key milestone for Abbott’s hematology business unit. Abbott is leading the way to providing a more efficient, complete lab solution that no competitor in the industry can match," said Luis de Luzuriaga, divisional vice president and general manager for Abbott’s hematology business. "With the Alinity family of harmonized systems, Abbott aims to simplify diagnostics testing across laboratory disciplines and help our customers improve patient outcomes."

Combining customer insights and engineering inspiration, Alinity hq was built from the ground up to help solve every day operational challenges and anticipated future needs for high-volume laboratories. Some unique capabilities of the system include:

  • Innovative, advanced optical technology combined with robust algorithms to handle normal and pathological samples

  • Design features that are intended to reduce manual steps and minimize errors, improve confidence in data and allow for uninterrupted operation

  • Scalable, modular design to customize configurations to better serve a broad spectrum of laboratories

Part of the Alinity family of harmonized systems, the Alinity hq analyzer has an intuitive user interface with iconography, color coding and reporting features shared by all Alinity instruments. The Alinity family also uses a common method for sample loading and reagent management, which helps labs simplify technician training.  

To learn more about the Alinity hq analyzer and the Alinity family of harmonized systems visit corelaboratory.abbott/hematology.

About Alinity

Abbott's Alinity family of harmonized solutions is unprecedented in the diagnostics industry, working together to address the challenges of using multiple diagnostics platforms and simplify diagnostic testing. Alinity systems are designed to be more efficient – running more tests in less space, generating test results faster and minimizing human errors – while continuing to provide quality results.

The Alinity portfolio includes clinical chemistry, immunoassay, blood and plasma screening, point of care, hematology and molecular diagnostics, along with Abbott’s AlinIQ—a first-of-its-kind, holistic suite of professional services that combines expertise with process analysis and informatics. Alinity is helping labs and hospital systems solve some of their most pressing challenges to deliver better patient care with fewer resources. To learn more, visit www.abbott.com/alinity.

About Abbott:

At Abbott, we're committed to helping you live your best possible life through the power of health. For more than 125 years, we've brought new products and technologies to the world -- in nutrition, diagnostics, medical devices and branded generic pharmaceuticals -- that create more possibilities for more people at all stages of life. Today, 94,000 of us are working to help people live not just longer, but better, in the more than 150 countries we serve.

Connect with us at www.abbott.com, on Facebook at www.facebook.com/Abbott and on Twitter @AbbottNews and @AbbottGlobal. 

*Note: Local product availability may vary depending on geographic location

For further information: Abbott Media: Tracy Sorrentino, +1 (224) 668-0179; or Abbott Financial: Michael Comilla, +1 (224) 668-1872
true
accessibility

You are about to exit for another Abbott country or region specific website

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.


The website you have requested also may not be optimized for your specific screen size.

Do you wish to continue and exit this website?

yesno
accessibility

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?

yesno